We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Kumar - Weekly Dosing of the Investigational Oral Proteasome Inhibitor MLN9708 in Patients with Relapsed and/or Refractory Multiple Myeloma: Results From a Phase 1 Dose-Escalation Study
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota, USA
12.06.11

Be the first to comment

 related articles